摘要:
Disclosed are compounds represented by structural formula methods of producing compounds represented by structural formula, and their use in inhibiting oxidation in an oxidizable material.
摘要:
A process for preparing a triazine-based precursor for producing a micro-particulate complex containing a far infrared-emissive silica particle comprises steps of: a) subjecting 2-4-6-trichloro-1,3,5-triazine and a first nucleophilic compound to a displacement reaction in the presence of a first solvent at a first temperature range to form an intermediate; and b) subjecting the intermediate and a second nucleophilic compound to a further displacement reaction in the presence of a second solvent at a second temperature range higher than the first temperature range.
摘要:
Disclosed are compounds represented by structural formula methods of producing compounds represented by structural formula, and their use in inhibiting oxidation in an oxidizable material.
摘要:
Methods of treating a TRPC5 mediated disorder in a subject by administering an effective amount of a TRPC5 antagonist, such as a compound disclosed herein, are described.
摘要:
The present invention concerns process for obtaining melamine at high purity characterized by comprising the steps of:—quenching a melamine melt, deprived of off-gases of the melamine synthesis and containing melamine impurities such as ammeline, ammelide and polycondensates, with an aqueous solution comprising ammonia under conditions such to substantially convert polycondensates into melamine, obtaining a melamine solution substantially free of polycondensates, recovering melamine from said melamine solution by melamine crystallization, obtaining melamine crystals and a melamine crystallization mother liquor,—treating said crystallization melamine mother liquor under conditions such to convert at least a portion of its ammeline content into ammelide and melammine, obtaining a treated mother liquid having at least a reduced ammeline content. The invention also concerns a high-pressure non-catalytic plant for the production of high-purity melamine implementing the above process and apparatuses suitable to be used in this plant.
摘要:
The present invention concerns process for obtaining melamine at high purity characterized by comprising the steps of:—quenching a melamine melt, deprived of off-gases of the melamine synthesis and containing melamine impurities such as ammeline, ammelide and polycondensates, with an aqueous solution comprising ammonia under conditions such to substantially convert polycondensates into melamine, obtaining a melamine solution substantially free of polycondensates, recovering melamine from said melamine solution by melamine crystallization, obtaining melamine crystals and a melamine crystallization mother liquor,—treating said crystallization melamine mother liquor under conditions such to convert at least a portion of its ammeline content into ammelide and melammine, obtaining a treated mother liquid having at least a reduced ammeline content. The invention also concerns a high-pressure non-catalytic plant for the production of high-purity melamine implementing the above process and apparatuses suitable to be used in this plant.
摘要:
The present invention provides novel compounds having a P2X3 and/or P2X2/3 receptor antagonistic effect.A pharmaceutical composition having an analgesic effect or an improving effect of urination disorder comprising a compound of the formula (I): wherein Rh and Rj are taken together to form a bond; Ra and Rb and/or Rd and Re are taken together to form oxo or the like; Rc is hydrogen, substituted or unsubstituted alkyl or the like; Rf is —(CR4aR4b)n—R2; R4a and R4b are hydrogen, substituted or unsubstituted alkyl or the like; R2 is substituted or unsubstituted cycloalkyl or the like; n is an integer of 1 to 4; —Rg is —X—R3; —X— is —O—, —S— or the like; R3 is substituted or unsubstituted cycloalkyl or the like, or its pharmaceutically acceptable salt or a solvate thereof.